Research on monthly GLP-1 treatments for obesity is showing promise as a potentially more manageable alternative. Some studies have reported weight loss efficacy with monthly dosing, although tolerability concerns have also been raised. The landscape for weight loss medication is evolving, with various GLP-1 treatments and other innovations being explored for their potential in obesity management.